Here, using transgenic mice models we have confirmed that glioma MPs (i.e. CD11b+/CD45high cells) mostly arose from circulating Gr1+ cells and expressed Arg1 (an M2 marker) shortly after trafficking into tumors. This evidence concerns the gene ARG1 and glioma.